Prometheus' spirit: quality survival in advanced hepatocellular carcinoma after gemcitabine and cisplatin-based chemotherapy

Doval DC, Pande SB, Sharma JB, Pavithran K, Jena A, Vaid AK
Correspondence: Dr Dinesh C Doval, dcdoval@yahoo.com

ABSTRACT
In advanced virus-induced hepatocellular carcinoma (HCC) associated with cirrhosis, the average survival is four months. We report a 56-year-old man with a large-volume advanced HCC, in whom gemcitabine and cisplatin-based chemotherapy resulted in near-complete regression, and quality survival of 24 months.

Keywords: alpha foetoprotein, cisplatin, gemcitabine, hepatocellular carcinoma, liver cancer, liver cirrhosis
Singapore Med J 2008; 49(10): e293-e295